Oncovir might rather have NWBO stock through a merger or other agreement, burn any shorts and immediately bump up valuation over big pharma low ball bids all in one fell swoop. The value of both companies would rise significantly and the news would get the attention of everyone even without announcing an DCVax approval because Oncovir can talk about it’s product and it’s importance to NWBO and future cancer patients because it is already being sold. Anyone see why folks are already talking “vetted” like this?; ). The media attention that NWBO can’t get easily Oncovir can. Next up (maybe), Charles River Labs!; ). Best wishes.
News 
Market Data 
Discover 
